Why the study?
PAH patients with pregnancy have high maternal mortality, motivating evaluation of MDT management and clinical outcomes during the perinatal period.
Does multidisciplinary team management improve maternal and neonatal survival in pregnant patients with pulmonary arterial hypertension?
Comparison
MDT management and pulmonary vasodilator therapy
Design
Retrospective single-center study
Authors
Loading...
May support MDT consideration in PAH pregnancies; hypothesis-generating and requires prospective validation.
Does multidisciplinary team management improve maternal and neonatal survival in pregnant patients with pulmonary arterial hypertension?
Multidisciplinary team management and pulmonary vasodilator therapy during the perinatal period achieved a 91.7% maternal survival rate in pregnant patients with pulmonary arterial hypertension.
Shu et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: